Stanley P Leong

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma
    S P Leong
    Department of Surgery, University of California San Francisco Mount Zion Cancer Center, 94115, USA
    Arch Dermatol 135:1472-6. 1999
  2. ncbi request reprint Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, UCSF Comprehensive Cancer Center, and UCSF Medical Center at Mount Zion, San Francisco, California, USA
    Ann Surg Oncol 11:192S-7S. 2004
  3. ncbi request reprint Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco Mount Zion Medical Center and UCSF Comprehensive Cancer Center, 1600 Divisadero Street, Room C333, San Francisco, CA 94143, USA
    Curr Treat Options Oncol 5:185-94. 2004
  4. ncbi request reprint Selective sentinel lymphadenectomy for breast cancer in the United States
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco, CA 94143, USA
    Asian J Surg 27:268-74. 2004
  5. ncbi request reprint Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites
    Stanley P L Leong
    Department of Surgery, UCSF Comprehensive Cancer Center at Mount Zion, San Francisco, California 94143 1674, USA
    Clin Nucl Med 30:150-8. 2005
  6. ncbi request reprint Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, Box 1674, San Francisco, California 94143, USA
    World J Surg 29:683-91. 2005
  7. ncbi request reprint Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Arch Otolaryngol Head Neck Surg 132:370-3. 2006
  8. ncbi request reprint Clinical patterns of metastasis
    Stanley P L Leong
    Department of Surgery, University of California, and UCSF Comprehensive Cancer Center, San Francisco, CA, USA
    Cancer Metastasis Rev 25:221-32. 2006
  9. ncbi request reprint Paradigm shift of staging and treatment for early breast cancer in the sentinel lymph node era
    Stanley P L Leong
    Department of Surgery, University of California and UCSF Comprehensive Cancer Center at Mount Zion, San Francisco, California 94143 1674, USA
    Breast J 12:S128-33. 2006
  10. ncbi request reprint Future perspectives on malignant melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1674, USA
    Surg Clin North Am 83:453-6, x. 2003

Detail Information

Publications56

  1. ncbi request reprint Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma
    S P Leong
    Department of Surgery, University of California San Francisco Mount Zion Cancer Center, 94115, USA
    Arch Dermatol 135:1472-6. 1999
    ..To evaluate discordancy between clinical predictions and lymphatic drainage patterns of primary cutaneous melanoma as determined by preoperative lymphoscintigraphy and intraoperative lymphatic mapping of sentinel lymph nodes (SLNs)...
  2. ncbi request reprint Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, UCSF Comprehensive Cancer Center, and UCSF Medical Center at Mount Zion, San Francisco, California, USA
    Ann Surg Oncol 11:192S-7S. 2004
    ..Better understanding of the molecular and genetic mechanisms of metastasis will be critical to select high-risk patients for adjuvant therapy...
  3. ncbi request reprint Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco Mount Zion Medical Center and UCSF Comprehensive Cancer Center, 1600 Divisadero Street, Room C333, San Francisco, CA 94143, USA
    Curr Treat Options Oncol 5:185-94. 2004
    ..A complete LN dissection is performed if the SLN is positive. It is important to follow the clinical outcome of patients undergoing SSL, thus its role can be further defined...
  4. ncbi request reprint Selective sentinel lymphadenectomy for breast cancer in the United States
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco, CA 94143, USA
    Asian J Surg 27:268-74. 2004
    ..SSL is rapidly evolving into a standard approach for staging primary breast cancer in the United States, without the maturation of results from clinical trials...
  5. ncbi request reprint Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites
    Stanley P L Leong
    Department of Surgery, UCSF Comprehensive Cancer Center at Mount Zion, San Francisco, California 94143 1674, USA
    Clin Nucl Med 30:150-8. 2005
    ..Preoperative lymphoscintigraphy was used to identify and classify SLN drainage basins and patterns of drainage...
  6. ncbi request reprint Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, Medical Center at Mount Zion and CSF Comprehensive Cancer Center, 1600 Divisadero Street, Box 1674, San Francisco, California 94143, USA
    World J Surg 29:683-91. 2005
    ..CI 1.20,2.98), and age (HR= 1.26 95% CI 1.08, 1.47). SLN status was the most significant factor for melanoma recurrence and death. Other important predictors include tumor thickness, ulceration, lymphatic invasion, and mitotic index...
  7. ncbi request reprint Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco, CA 94115, USA
    Arch Otolaryngol Head Neck Surg 132:370-3. 2006
    ..To determine the impact of sentinel lymph node (SLN) status and other risk factors on recurrence and overall survival in head and neck melanoma patients...
  8. ncbi request reprint Clinical patterns of metastasis
    Stanley P L Leong
    Department of Surgery, University of California, and UCSF Comprehensive Cancer Center, San Francisco, CA, USA
    Cancer Metastasis Rev 25:221-32. 2006
    ..Beyond the clinical patterns of metastasis, it is imperative to understand the biology of metastasis and to characterize patterns of metastasis perhaps due to heterogeneous clones based on their molecular signatures...
  9. ncbi request reprint Paradigm shift of staging and treatment for early breast cancer in the sentinel lymph node era
    Stanley P L Leong
    Department of Surgery, University of California and UCSF Comprehensive Cancer Center at Mount Zion, San Francisco, California 94143 1674, USA
    Breast J 12:S128-33. 2006
    ..The challenge in the future will be to dissect these different patterns of metastasis based on molecular or genetic markers. Such information will be critical to select high-risk patients for adjuvant therapy...
  10. ncbi request reprint Future perspectives on malignant melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94143 1674, USA
    Surg Clin North Am 83:453-6, x. 2003
    ..If such mechanisms can be understood, potential therapeutic maneuvers can be developed to prevent the process of micrometastasis...
  11. ncbi request reprint Selective sentinel lymphadenectomy for malignant melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco, University of California at San Francisco Comprehensive Cancer Center at Mount Zion, 1600 Divisadero Street, San Francisco, CA 94143 1674, USA
    Surg Clin North Am 83:157-85, vii. 2003
    ..It is important for investigators involved with SSL to follow the clinical outcome of their patients so that the role of SSL can be further defined...
  12. ncbi request reprint Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma
    Stanley P L Leong
    Department of Surgery, Melanoma Center, University of California, San Francisco Medical Center at Mount Zion, San Francisco, California, USA
    Ann Surg Oncol 10:196-200. 2003
    ..The aim of our study was to determine whether delayed SSL is useful in detecting micrometastasis to the regional basin in patients with previous WLE of an extremity melanoma...
  13. ncbi request reprint Future perspectives on selective sentinel lymphadenectomy
    S P Leong
    Department of Surgery, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94115, USA
    Surg Clin North Am 80:1839-44. 2000
    ..The techniques of harvesting are being developed in other solid cancers, such as gynecologic and gastrointestinal cancer. Cellular and molecular techniques are being used to study the mechanism of micrometastasis...
  14. ncbi request reprint Cytokine profiles of sentinel lymph nodes draining the primary melanoma
    Stanley P L Leong
    Department of Surgery, University of California at San Francisco Comprehensive Cancer Center Mount Zion, 94143 1674, USA
    Ann Surg Oncol 9:82-7. 2002
    ..The sentinel lymph node (SLN) draining the primary melanoma is the first echelon node where micrometastasis is established. SLNs may be the initial sites of antigen presentation associated with immune responses...
  15. ncbi request reprint Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma
    S P Leong
    Department of Surgery, University of California Mount Zion Medical Center, San Francisco 94143 1674, USA
    Ann Surg Oncol 7:361-6. 2000
    ..This procedure identifies the SLN either visually by injecting isosulfan blue dye around the primary melanoma site or by handheld gamma probe after radiocolloid injection...
  16. ncbi request reprint The role of sentinel lymph nodes in malignant melanoma
    S P Leong
    Department of Surgery, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94115, USA
    Surg Clin North Am 80:1741-57. 2000
    ..Based on the clinical outcome data of selective sentinel lymph node dissection, micrometastasis to the SLNs carries a poor prognosis for patients with primary invasive melanoma...
  17. doi request reprint Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?
    Liang Chih Liu
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
    J Am Coll Surg 207:853-8. 2008
    ..We hypothesized that the node with the highest radioactivity would have the strongest probability of being a positive SLN, and we sought to determine the lowest radioactive count of a node harboring cancer...
  18. ncbi request reprint Age as a prognostic factor in patients with localized melanoma and regional metastases
    Charles M Balch
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 20:3961-8. 2013
    ..We postulated that the worse prognosis of melanoma with advancing age reflected more aggressive tumor biology and that in younger patients the prognosis would be more favorable...
  19. doi request reprint Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience
    Liang Chih Liu
    Department of Surgery, Helen Diller and Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California, USA
    Cancer 117:250-8. 2011
    ..The objective of the current study was to determine the accuracy of intraoperative frozen section (IFS) of SLNs during breast cancer surgery...
  20. ncbi request reprint Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study
    Sandra L Wong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Ann Surg Oncol 13:809-16. 2006
    ..This multi-institutional study was undertaken to characterize patterns of failure and survival rates in these patients and to compare results with those of positive-SLN patients who underwent CLND...
  21. doi request reprint Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer
    Julie E Lang
    Department of Surgery and UCSF Comprehensive Cancer Center, UCSF, San Francisco, CA 94143 1674, USA
    Breast J 15:242-6. 2009
    ..57), or overall survival (p = 0.70). Positive non-SLNs removed during SSL are not a significant risk factor for additional positive nodes on completion axillary nodal dissection (CALND) or for worse survival than positive SLNs...
  22. ncbi request reprint Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA 94115, USA
    J Clin Oncol 24:4565-9. 2006
    ..To assess the prognostic significance of nuclear receptor coactivator-3 (NCOA3) overexpression in primary cutaneous melanoma...
  23. doi request reprint Novel role for RGS1 in melanoma progression
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, UCSF Comprehensive Cancer Center, Department of Dermatology, University of California San Francisco, San Francisco, CA 94115, USA
    Am J Surg Pathol 32:1207-12. 2008
    ..0039). These results validate the role of RGS1 as a novel prognostic marker for melanoma given its impact on the survival associated with melanoma...
  24. ncbi request reprint Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients
    Charles M Balch
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 21:1075-81. 2014
    ..Melanoma had lower survival rates compared to younger patients. We postulated that the incidence of nodal metastasis would therefore be higher among older melanoma patients...
  25. pmc Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases
    Charles M Balch
    Department of Surgery, Johns Hopkins Medical Institutions, 600 N Wolfe St, Osler 624, Baltimore, MD 21287, USA
    J Clin Oncol 28:2452-9. 2010
    ..To determine the survival rates and independent predictors of survival using a contemporary international cohort of patients with stage III melanoma...
  26. ncbi request reprint Impact of multiple lymphatic channel drainage to a single nodal basin on outcomes in melanoma
    James K Wall
    Department of Surgery, UCSF, San Francisco, CA 94115, USA
    Arch Surg 142:753-7; discussion 756-8. 2007
    ..To determine the impact of multiple lymphatic channels (MLCs) on outcome in melanoma...
  27. doi request reprint Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma
    Dale Han
    Dale Han, Jonathan S Zager, Sanjana Iyengar, Mia Djulbegovic, Jaimie L Weber, Suroosh S Marzban, Vernon K Sondak, and Jane L Messina, Moffitt Cancer Center, Tampa Eli Avisar, University of Miami, Miami, FL Yu Shyr, Heidi Chen, and Lynne D Berry, Vanderbilt University School of Medicine, Nashville, TN John T Vetto, Oregon Health and Science University, Portland, OR Richard L White, Carolinas Medical Center, Charlotte, NC Barbara Pockaj, Mayo Clinic, Scottsdale Robert Krouse, Southern Arizona Veterans Administration Health Care System, Tucson, AZ Nicola Mozzillo, Istituto Nazionale dei Tumori Fondazione Pascale, Naples, Italy Kim James Charney, St Joseph Hospital, Orange and Mohammed Kashani Sabet and Stanley P Leong, California Pacific Medical Center and Research Institute, San Francisco, CA
    J Clin Oncol 31:4387-93. 2013
    ..Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are continually evolving. We present a large multi-institutional study to determine factors predictive of sentinel lymph node (SLN) metastasis in thin melanoma...
  28. doi request reprint Analysis of sentinel lymph node positivity in patients with thin primary melanoma
    Suraj S Venna
    Auerback Melanoma Research Laboratory and Melanoma Center, University of California, San Francisco, San Francisco, California, USA
    J Am Acad Dermatol 68:560-7. 2013
    ..A minority of patients with T1 melanoma will have a positive sentinel lymph node (SLN) biopsy (SLNB) finding. Identifying who will develop metastatic disease is important in determining prognosis and treatment...
  29. doi request reprint Selection of tumorigenic melanoma cells using ALDH
    Jim B Boonyaratanakornkit
    Department of Dermatology, University of California, San Francisco, San Francisco, California, USA
    J Invest Dermatol 130:2799-808. 2010
    ..Thus, ALDH(+) melanoma cells have enhanced tumorigenicity over ALDH(-) cells and superior self-renewal ability...
  30. ncbi request reprint Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation
    Julie E Lang
    Department of Surgery, University of California San Francisco, San Francisco, CA 94114, USA
    J Am Coll Surg 199:856-62. 2004
    ..It is important to determine whether SSL can be used after neoadjuvant chemotherapy and whether clinical node status at presentation affects accuracy of SSL...
  31. ncbi request reprint Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer
    Yah Yuen Tan
    Department of Surgery, UCSF Medical Center at Mount Zion, San Francisco, California, USA
    Breast J 11:338-43. 2005
    ..These patients can be identified preoperatively based on imaging and biopsy criteria, allowing the option of selective intraoperative pathologic evaluation of the sentinel node and immediate completion axillary dissection as necessary...
  32. ncbi request reprint Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients
    Chen Teng Wu
    Department of Surgery, University of California, San Francisco UCSF Medical Center at Mount Zion, 94143 1674, USA
    Breast J 9:86-90. 2003
    ..The possibility of failure to get the SLN should be explained to patients before surgery. Axillary lymph node dissection (ALND) should be done if selective SLN dissection is not successful...
  33. ncbi request reprint Selective sentinel lymph node mapping and dissection for malignant melanoma
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Cancer Treat Res 111:39-64. 2002
  34. ncbi request reprint Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment
    Catherine Park
    Department of Radiation Oncology, University of California, Mount Zion Medical Center, the UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Breast J 11:29-33. 2005
    ..These factors may aid in the selection of patients who might benefit from further staging or treatment of the IMNs...
  35. ncbi request reprint The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer
    Yang Guo Fan
    Department of Surgery, University of California San Francisco Medical Center at Mount Zion, San Francisco, 94143 1674, USA
    Ann Surg Oncol 12:705-11. 2005
    ..We also report our experience with disease relapse in the era of SSL and attempt to correlate this with SLN tumor burden...
  36. pmc A multimarker prognostic assay for primary cutaneous melanoma
    Mohammed Kashani-Sabet
    Auerback Melanoma Research Laboratory and Melanoma Center, Comprehensive Cancer Center, and Departments of Pathology, Surgery, and Urology, University of California San Francisco, San Francisco, California, USA
    Clin Cancer Res 15:6987-92. 2009
    ..To determine the prognostic significance of a multimarker assay incorporating expression levels of three molecular markers in primary cutaneous melanoma...
  37. ncbi request reprint Coexisting tattoo pigment and metastatic melanoma in the same sentinel lymph node
    Adnan A Jaigirdar
    Departments of Surgery and Pathology, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center at Mount Zion, San Francisco, CA 94115, USA
    J Cutan Med Surg 13:321-5. 2009
    ..The principle of sentinel lymph node states that metastatic melanoma spreads in a predictable sequential fashion from the primary site to the regional lymph node basin...
  38. ncbi request reprint Osteopontin as a molecular prognostic marker for melanoma
    Javier Rangel
    Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center, San Francisco, California 94115, USA
    Cancer 112:144-50. 2008
    ..Osteopontin has been suggested as a marker of disease progression in patients with melanoma because of its overexpression in recent microarray analyses. However, its prognostic role in melanoma has not been fully defined...
  39. pmc The gene expression signatures of melanoma progression
    Christopher Haqq
    Auerback Melanoma Research Laboratory, Melanoma Center and Department of Dermatology, Cutaneous Oncology Program, University of California at San Francisco UCSF Comprehensive Cancer Center, San Francisco, CA 94115, USA
    Proc Natl Acad Sci U S A 102:6092-7. 2005
    ..The gene expression signatures identified here provide the basis for developing new diagnostics and targeting therapies for patients with malignant melanoma...
  40. ncbi request reprint Prognostic factors in patients with thick cutaneous melanoma (> 4 mm)
    Elizabeth Zettersten
    Melanoma Center, Cutaneous Oncology Program, University of California at San Francisco, Comprehensive Cancer Center, San Francisco, California 94115, USA
    Cancer 94:1049-56. 2002
    ..The current study was conducted to examine the role of multiple clinical and histologic factors in the prognostic assessment of patients with thick primary melanoma (> 4 mm, classified as T4)...
  41. ncbi request reprint Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease
    Edward P Miranda
    Department of Surgery, University of California San Francisco, 94143 1974, USA
    Arch Surg 139:831-6; discussion 836-7. 2004
    ....
  42. ncbi request reprint Prognostic significance of extent of ulceration in primary cutaneous melanoma
    Hege Grande Sarpa
    Melanoma Center, Cutaneous Oncology Program, Cancer Center, University of California, San Francisco, CA 94115, USA
    Am J Surg Pathol 30:1396-400. 2006
    ..These results suggest that no more than minimal ulceration is required to have a prognostic impact on melanoma survival...
  43. ncbi request reprint Selective sentinel lymphadenectomy for malignant melanoma, Merkel cell carcinoma, and squamous cell carcinoma
    Stanley P L Leong
    Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, USA
    Cancer Treat Res 127:39-76. 2005
    ..It is important for investigators involved with the SSL to follow the clinical outcome of these patients, so that the role of SSL can be further defined...
  44. ncbi request reprint Selective sentinel lymph node mapping and dissection for breast cancer
    Stanley P L Leong
    Sentinel Lymph Node Program, Department of Surgery, University of California, San Francisco Medical Center at Mount Zion, UCSF Comprehensive Cancer Center, San Francisco, California, USA
    Cancer Treat Res 111:65-79. 2002
  45. ncbi request reprint The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma
    Benjamin L Franc
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0252, USA
    Clin Nucl Med 30:787-91. 2005
    ....
  46. ncbi request reprint Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients
    Yah Yuen Tan
    Department of Surgery, UCSF Medical Center at Mount Zion and UCSF Comprehensive Cancer Center, San Francisco, California 94143 1674, USA
    Breast J 11:248-53. 2005
    ....
  47. ncbi request reprint Future perspectives and unanswered questions on cancer metastasis and the lymphovascular system
    Stanley P L Leong
    University of California San Francisco, San Francisco, California, USA
    Cancer Treat Res 135:293-6. 2007
  48. doi request reprint An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second 'primary' tumor
    Iris Z Ahronowitz
    Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
    J Cutan Pathol 38:801-7. 2011
    ..Our data calls into question prior reports alleging multiple cutaneous primaries of this very rare tumor...
  49. ncbi request reprint Detection of occult melanoma by preoperative positron emission tomography-computed tomography and intraoperative ultrasonography
    Brenda A Shoo
    Department of Dermatology, University of California San Francisco, CA 94143 1674, USA
    J Cutan Med Surg 14:130-5. 2010
    ..18F-Fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) has become a common imaging modality for detecting metastatic melanoma. However, the identification of lesions intraoperatively can be difficult...
  50. ncbi request reprint Image of the month: angiosarcoma of the breast
    Justin Parekh
    Department of Surgery, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94143, USA
    Arch Surg 140:809-10. 2005
  51. ncbi request reprint Future perspectives for cancer metastasis and the lymphovascular system
    Stanley P L Leong
    Department of Surgery, University of California, and UCSF Comprehensive Cancer Center, San Francisco, CA 94143 1674, USA
    Cancer Metastasis Rev 25:293-4. 2006
  52. ncbi request reprint Patterns of metastasis in human solid cancers
    Stanley P L Leong
    Department of Surgery, University of California San Francisco, California, USA
    Cancer Treat Res 135:209-21. 2007
  53. doi request reprint Getting to better cancer care: results of a society of surgical oncology survey
    Sandra L Wong
    Department of Surgery, Division of Surgical Oncology, University of Michigan, 1500 E Medical Center Drive, 3310 CCC, Ann Arbor, MI, 48109 5932, USA
    Ann Surg Oncol 15:2363-71. 2008
    ..A survey of its members was conducted to determine which domains of "outcomes" are important and relevant to surgical oncologists...
  54. ncbi request reprint Laparoscopic surgery for melanoma metastases to the adrenal gland
    Cord Sturgeon
    University of Feinberg School of Medicine, Division of Gastrointestinal and Endocrine Surgery, Chicago, IL 60611 2908, USA
    Expert Rev Anticancer Ther 4:837-41. 2004
    ..However, the natural history of laparoscopic surgery for these lesions is still unknown. The indications for and limitations of laparoscopic adrenalectomy for metastatic melanoma are discussed...
  55. ncbi request reprint Tumour-induced immune modulation of sentinel lymph nodes
    Alistair J Cochran
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at the University of California at Los Angeles, California 90095, USA
    Nat Rev Immunol 6:659-70. 2006
    ..Immune modulation of the lymph nodes can be reversed by granulocyte/macrophage colony-stimulating factor (GM-CSF), a finding that has implications for the future therapy of lymph-node metastases...
  56. pmc Loss of the eukaryotic initiation factor 3f in melanoma
    Adriana Doldan
    Department of Pathology, University of Arizona, Tucson, Arizona 85724, USA
    Mol Carcinog 47:806-13. 2008
    ..These data provide new insight into the understanding of the molecular pathogenesis of eIF3f during melanoma tumorigenesis...

Research Grants2

  1. Symposium on Cancer Metastasis and Lymphovascular System
    STANLEY LEONG; Fiscal Year: 2004
    ..abstract_text> ..
  2. International Symposium on Cancer Metastasis and the Lymphovascular System
    STANLEY LEONG; Fiscal Year: 2007
    ....